Skip to main content

Published locations for HR+/HER2-negative breast cancer: Adding palbociclib to fulvestrant prolongs PFS in phase 2

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. HR+/HER2-negative breast cancer: Adding palbociclib to fulvestrant prolongs PFS in phase 2

User login

  • Reset your password
  • /content/hr/her2-negative-breast-cancer-adding-palbociclib-fulvestrant-prolongs-pfs-phase-2
  • /hematology-oncology/article/250858/breast-cancer/hr/her2-negative-breast-cancer-adding-palbociclib
  • /breast-cancer-icymi/article/250858/breast-cancer/hr/her2-negative-breast-cancer-adding-palbociclib